As shown in Table 2 and Figure 1, patients with CHB and CHC as well as those with the other hepatic diseases (NAFLD, autoimmune hepatitis, PBC, and MTX-related hepatotoxicity) presented a statistically significant increase of Foxp3 mRNA levels compared to normal controls. Here, FOXP3 is linked to liver disorder.